Overview
Alomone Labs is a biotechnology company founded in 1989 and headquartered in Jerusalem, Israel, specializing in the development and production of research tools for membrane proteins. The company is particularly known for its expertise in ion channel and receptor biology, offering a comprehensive portfolio of antibodies, peptide toxins, small molecules, and recombinant proteins used in basic and applied research. Alomone initially gained recognition for isolating peptide toxins from animal venoms and later advanced to producing synthetic and recombinant toxins, expanding its capabilities in membrane protein research tools. Today, Alomone serves academic, pharmaceutical, and biotechnology researchers worldwide, with products widely used in neuroscience, cardiovascular research, cancer biology, and drug discovery.
Key techniques
Alomone products support specialized techniques focused on membrane protein biology, receptor signaling, and neuroscience research.
Product lines
Alomone Labs provides a specialized portfolio of reagents designed for membrane protein and receptor research.
Antibodies ›
Capabilities
Alomone integrates advanced protein chemistry and pharmacological expertise to develop highly specialized reagents for membrane protein research.
QC & documentation
Alomone provides detailed technical documentation and validation data to support reproducible research.
Lead time & shipping
Shipping timelines depend on product availability and destination.